MedPath

RTOG Foundation, Inc.

RTOG Foundation, Inc. logo
🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.rtog.org

Changes in DNA After Radiation Therapy in Patients With Prostate Cancer

Completed
Conditions
Prostate Cancer
First Posted Date
2009-05-12
Last Posted Date
2015-11-17
Lead Sponsor
Radiation Therapy Oncology Group
Target Recruit Count
13
Registration Number
NCT00899912
Locations
🇺🇸

Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States

🇺🇸

Georgia Cancer Center for Excellence at Grady Memorial Hospital, Atlanta, Georgia, United States

🇺🇸

Emory Crawford Long Hospital, Atlanta, Georgia, United States

and more 7 locations

Collecting and Storing Tissue Samples From Patients With Head and Neck Cancer

Completed
Conditions
Head and Neck Cancer
Interventions
Other: biologic sample preservation procedure
Procedure: biopsy
First Posted Date
2009-05-12
Last Posted Date
2015-11-13
Lead Sponsor
Radiation Therapy Oncology Group
Target Recruit Count
351
Registration Number
NCT00898300
Locations
🇺🇸

Val and Ann Browning Cancer Center at McKay-Dee Hospital Center, Ogden, Utah, United States

🇺🇸

Gibbs Regional Cancer Center at Spartanburg Regional Medical Center, Spartanburg, South Carolina, United States

🇺🇸

University of California Davis Cancer Center, Sacramento, California, United States

and more 95 locations

Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma

Phase 2
Completed
Conditions
Brain and Central Nervous System Tumors
Interventions
Radiation: 60 Gy radiotherapy
Radiation: 54 Gy radiotherapy
First Posted Date
2009-05-08
Last Posted Date
2023-09-08
Lead Sponsor
Radiation Therapy Oncology Group
Target Recruit Count
244
Registration Number
NCT00895622
Locations
🇺🇸

Winship Cancer Institute of Emory University, Atlanta, Georgia, United States

🇺🇸

University Cancer Center at University of Washington Medical Center, Seattle, Washington, United States

🇺🇸

Baptist-South Miami Regional Cancer Program, Miami, Florida, United States

and more 75 locations

Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery

Phase 2
Completed
Conditions
Bladder Cancer
Interventions
Drug: induction cisplatin
Drug: induction gemcitabine
Drug: induction 5-fluorouracil
Radiation: Induction QD radiation therapy
Radiation: Induction BID radiation therapy
Radiation: Consolidation QD radiation therapy
Radiation: Consolidation BID radiation therapy
Drug: consolidation gemcitabine
Drug: consolidation 5-fluorouracil
Drug: consolidation cisplatin
Procedure: Post-Induction Chemoradiotherapy Endoscopic Response Evaluation
Procedure: radical cystectomy
Drug: adjuvant gemcitabine
Drug: adjuvant cisplatin
First Posted Date
2008-10-22
Last Posted Date
2022-06-15
Lead Sponsor
Radiation Therapy Oncology Group
Target Recruit Count
70
Registration Number
NCT00777491
Locations
🇺🇸

Winship Cancer Institute of Emory University, Atlanta, Georgia, United States

🇺🇸

Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center, Boise, Idaho, United States

🇺🇸

Georgia Cancer Center for Excellence at Grady Memorial Hospital, Atlanta, Georgia, United States

and more 8 locations

Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and Neck

Phase 3
Completed
Conditions
Head and Neck Cancer
Interventions
Procedure: conventional surgery
Radiation: low-LET cobalt-60 gamma ray therapy
Radiation: low-LET electron therapy
Radiation: low-LET photon therapy
Radiation: radiation therapy
First Posted Date
2008-10-13
Last Posted Date
2014-01-24
Lead Sponsor
Radiation Therapy Oncology Group
Target Recruit Count
1113
Registration Number
NCT00771641

Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer

Phase 3
Completed
Conditions
Prostate Cancer
Interventions
Drug: flutamide
Drug: goserelin acetate
Radiation: low-LET photon therapy
First Posted Date
2008-10-09
Last Posted Date
2017-01-04
Lead Sponsor
Radiation Therapy Oncology Group
Target Recruit Count
1322
Registration Number
NCT00769548

Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

Phase 3
Completed
Conditions
Prostate Cancer
First Posted Date
2008-10-07
Last Posted Date
2014-01-28
Lead Sponsor
Radiation Therapy Oncology Group
Registration Number
NCT00767286

Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer

Phase 1
Completed
Conditions
Lung Cancer
Interventions
Radiation: SBRT 42.5 Gy
Radiation: SBRT 40.0 Gy
Radiation: SBRT 50.0 Gy
Radiation: SBRT 45.0 Gy
Radiation: SBRT 55.0 Gy
Radiation: SBRT 60.0 Gy
Radiation: SBRT 47.5 Gy
Radiation: SBRT 52.5 Gy
Radiation: SBRT 57.5 Gy
First Posted Date
2008-09-10
Last Posted Date
2022-06-09
Lead Sponsor
Radiation Therapy Oncology Group
Target Recruit Count
120
Registration Number
NCT00750269
Locations
🇺🇸

CCOP - Mount Sinai Medical Center, Miami Beach, Florida, United States

🇺🇸

Norton Suburban Hospital, Louisville, Kentucky, United States

🇺🇸

Radiation Oncology Centers - Cameron Park, Cameron Park, California, United States

and more 55 locations

Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer

Phase 2
Terminated
Conditions
Head and Neck Cancer
Interventions
Drug: cisplatin
Radiation: radiation therapy
Drug: vandetanib
First Posted Date
2008-07-22
Last Posted Date
2015-11-17
Lead Sponsor
Radiation Therapy Oncology Group
Target Recruit Count
34
Registration Number
NCT00720083
Locations
🇺🇸

Case Comprehensive Cancer Center, Cleveland, Ohio, United States

🇺🇸

Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States

🇺🇸

York Cancer Center at Apple Hill Medical Center, York, Pennsylvania, United States

and more 60 locations

Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer

Phase 2
Completed
Conditions
Head and Neck Cancer
Xerostomia
Interventions
Procedure: ALTENS
Drug: Pilocarpine
First Posted Date
2008-04-11
Last Posted Date
2019-11-19
Lead Sponsor
Radiation Therapy Oncology Group
Target Recruit Count
196
Registration Number
NCT00656513
Locations
🇺🇸

Schiffler Cancer Center at Wheeling Hospital, Wheeling, West Virginia, United States

🇨🇦

McGill Cancer Centre at McGill University, Montreal, Quebec, Canada

🇺🇸

Hospital of Saint Raphael, New Haven, Connecticut, United States

and more 17 locations
© Copyright 2025. All Rights Reserved by MedPath